While many CNOs are focused on the present, they need to look to the future and consider what will happen once they move on.

President Trump sent letters Thursday to 17 of the world's largest drug companies, telling them to take more steps to slash the prices of prescription drugs to match the lowest price in certain ...

Coronary artery calcium tests are comparatively inexpensive but patients usually must pay for it out-of-pocket. Medicare rarely covers it.

Fitch Ratings has revised UnitedHealth Group's outlook to negative from stable while affirming the insurer financial strength ratings of its subsidiaries at 'AA-'. The rating agency maintained ...

In the most recent episode of The Winning Edge, Moffitt Cancer Center’s VP of Revenue Cycle Lynn Ansley dove into the ...

While competitors continue to struggle with spiraling healthcare costs, Aetna and CVS are celebrating an 8.4% increase in second-quarter revenues. The insurer is achieving this through nimble ...

AbsoluteCare, which specializes in value-based integrated healthcare, has secured $135 million in equity financing from four investors: CVS Health Ventures, Kinderhook Industries, Pacific Life and ...

By subtly tweaking classic medical dilemmas, researchers revealed that large language models often default to familiar or intuitive answers, even when they contradict the facts. These “fast thinking” ...

How automation is optimizing revenue cycle operations, lowering costs, and improving the payment experience for both employees and patients With margins tightening and payment collection getting ...

At her confirmation hearing before the Senate on July 9, Susan Monarez garnered praise from the Republican chairman, Sen. Bill Cassidy, who is a physician, for her commitment to rebuilding public ...

Children may be more likely to survive a rare, potentially fatal influenza complication if they receive rapid treatment for brain swelling and extreme immune responses, a Stanford Medicine-led report ...

The FDA's polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of biotech executives, patient groups and conservative allies of President Donald Trump. Dr. Vinay ...